{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:36:15Z","timestamp":1787006175772,"version":"build-2736575974"},"reference-count":25,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:00:00Z","timestamp":1721174400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82173883"],"award-info":[{"award-number":["82173883"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Science and Technology Foundation of Xuzhou","award":["KC23255"],"award-info":[{"award-number":["KC23255"]}]},{"name":"the Natural Science Foundation of the Jiangsu Higher Education Institutions of China","award":["18KA350002"],"award-info":[{"award-number":["18KA350002"]}]},{"name":"the Provincial Commission of Health and Family Planning in Jiangsu Province","award":["H2017079"],"award-info":[{"award-number":["H2017079"]}]},{"name":"the Science and Technology Planning Project of Jiangsu Province","award":["BE2019636"],"award-info":[{"award-number":["BE2019636"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Obstetrics and Gynaecology"],"published-print":{"date-parts":[[2024,12,31]]},"DOI":"10.1080\/01443615.2024.2378489","type":"journal-article","created":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T07:33:55Z","timestamp":1721201635000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Follicular fluid lipidomics analysis reveals altered lipid signatures in patients with polycystic ovary syndrome"],"prefix":"10.1080","volume":"44","author":[{"given":"Qing","family":"He","sequence":"first","affiliation":[{"name":"Affiliated Xuzhou Clinical College of Xuzhou Medical University, Xuzhou Medical University","place":["Xuzhou, China"]},{"name":"Center for Reproductive Medicine, Xuzhou Central Hospital","place":["Xuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Guo","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University","place":["Xuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqiang","family":"Lv","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University","place":["Xuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junchao","family":"Cui","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University","place":["Xuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Meng","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University","place":["Xuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Gao","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University","place":["Xuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiachen","family":"Ma","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University","place":["Xuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Zhou","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University","place":["Xuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijuan","family":"Cao","sequence":"additional","affiliation":[{"name":"Affiliated Xuzhou Clinical College of Xuzhou Medical University, Xuzhou Medical University","place":["Xuzhou, China"]},{"name":"Center for Reproductive Medicine, Xuzhou Central Hospital","place":["Xuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,7,17]]},"reference":[{"issue":"1","key":"e_1_3_5_2_1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13048-021-00885-y","article-title":"Lipidomics analysis of human follicular fluid form normal-weight patients with polycystic ovary syndrome: a pilot study","volume":"14","author":"Ban Y.","year":"2021","unstructured":"Ban, Y., et\u00a0al., 2021. Lipidomics analysis of human follicular fluid form normal-weight patients with polycystic ovary syndrome: a pilot study. Journal of Ovarian Research, 14 (1), 135.","journal-title":"Journal of Ovarian Research"},{"key":"e_1_3_5_3_1","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.cca.2019.11.016","article-title":"Metabolic alterations associated with polycystic ovary syndrome: a UPLC Q-Exactive based metabolomic study","volume":"502","author":"Chen X.","year":"2020","unstructured":"Chen, X., et\u00a0al., 2020. Metabolic alterations associated with polycystic ovary syndrome: a UPLC Q-Exactive based metabolomic study. Clinica Chimica Acta, 502, 280\u2013286.","journal-title":"Clinica Chimica Acta"},{"issue":"6","key":"e_1_3_5_4_1","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/humrep\/deac050","article-title":"Association of maternal polycystic ovary syndrome and diabetes with preterm birth and offspring birth size: a population-based cohort study","volume":"37","author":"Chen X.","year":"2022","unstructured":"Chen, X., Gissler, M., and Lavebratt, C., 2022. Association of maternal polycystic ovary syndrome and diabetes with preterm birth and offspring birth size: a population-based cohort study. Human Reproduction, 37 (6), 1311\u20131323.","journal-title":"Human Reproduction"},{"issue":"1","key":"e_1_3_5_5_1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10815-014-0375-0","article-title":"Follicular fluid lipid fingerprinting from women with PCOS and hyper response during IVF treatment","volume":"32","author":"Cordeiro F.B.","year":"2015","unstructured":"Cordeiro, F.B., et\u00a0al., 2015. Follicular fluid lipid fingerprinting from women with PCOS and hyper response during IVF treatment. Journal of Assisted Reproduction and Genetics, 32 (1), 45\u201354.","journal-title":"Journal of Assisted Reproduction and Genetics"},{"key":"e_1_3_5_6_1","doi-asserted-by":"crossref","first-page":"960274","DOI":"10.3389\/fendo.2022.960274","article-title":"Follicular fluid lipidomic profiling reveals potential biomarkers of polycystic ovary syndrome: a pilot study","volume":"13","author":"Ding Y.","year":"2022","unstructured":"Ding, Y., et\u00a0al., 2022. Follicular fluid lipidomic profiling reveals potential biomarkers of polycystic ovary syndrome: a pilot study. Frontiers in Endocrinology, 13, 960274.","journal-title":"Frontiers in Endocrinology"},{"issue":"11","key":"e_1_3_5_7_1","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1093\/humrep\/deac210","article-title":"Polycystic ovary syndrome and risk of adverse pregnancy outcomes: a registry linkage study from Massachusetts","volume":"37","author":"Farland L.V.","year":"2022","unstructured":"Farland, L.V., et\u00a0al., 2022. Polycystic ovary syndrome and risk of adverse pregnancy outcomes: a registry linkage study from Massachusetts. Human Reproduction, 37 (11), 2690\u20132699.","journal-title":"Human Reproduction"},{"issue":"1","key":"e_1_3_5_8_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/REP-22-0023","article-title":"Follicular free fatty acid metabolic signatures and their effects on oocyte competence in non-obese PCOS patients","volume":"164","author":"Feng Y.","year":"2022","unstructured":"Feng, Y., et\u00a0al., 2022. Follicular free fatty acid metabolic signatures and their effects on oocyte competence in non-obese PCOS patients. Reproduction, 164 (1), 1\u20138.","journal-title":"Reproduction"},{"issue":"7","key":"e_1_3_5_9_1","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.tem.2017.03.005","article-title":"Sphingolipids and lipoproteins in health and metabolic disorders","volume":"28","author":"Iqbal J.","year":"2017","unstructured":"Iqbal, J., et\u00a0al., 2017. Sphingolipids and lipoproteins in health and metabolic disorders. Trends in Endocrinology and Metabolism, 28 (7), 506\u2013518.","journal-title":"Trends in Endocrinology and Metabolism"},{"issue":"2","key":"e_1_3_5_10_1","first-page":"319","article-title":"Hormonal and metabolic effects of coenzyme Q10 and\/or vitamin E in patients with polycystic ovary syndrome","volume":"104","author":"Izadi A.","year":"2019","unstructured":"Izadi, A., et\u00a0al., 2019. Hormonal and metabolic effects of coenzyme Q10 and\/or vitamin E in patients with polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism, 104 (2), 319\u2013327.","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"issue":"4","key":"e_1_3_5_11_1","doi-asserted-by":"crossref","first-page":"4522","DOI":"10.18632\/oncotarget.23393","article-title":"Lipidomics reveals altered biosynthetic pathways of glycerophospholipids and cell signaling as biomarkers of the polycystic ovary syndrome","volume":"9","author":"Jov\u00e9 M.","year":"2018","unstructured":"Jov\u00e9, M., et\u00a0al., 2018. Lipidomics reveals altered biosynthetic pathways of glycerophospholipids and cell signaling as biomarkers of the polycystic ovary syndrome. Oncotarget, 9 (4), 4522\u20134536.","journal-title":"Oncotarget"},{"issue":"1","key":"e_1_3_5_12_1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/humrep\/deu268","article-title":"Overlap of proteomics biomarkers between women with pre-eclampsia and PCOS: a systematic review and biomarker database integration","volume":"30","author":"Khan G.H.","year":"2015","unstructured":"Khan, G.H., et\u00a0al., 2015. Overlap of proteomics biomarkers between women with pre-eclampsia and PCOS: a systematic review and biomarker database integration. Human Reproduction, 30 (1), 133\u2013148.","journal-title":"Human Reproduction"},{"key":"e_1_3_5_13_1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2147\/TACG.S200341","article-title":"Genetic basis of polycystic ovary syndrome (PCOS): current perspectives","volume":"12","author":"Khan M.J.","year":"2019","unstructured":"Khan, M.J., Ullah, A., and Basit, S., 2019. Genetic basis of polycystic ovary syndrome (PCOS): current perspectives. The Application of Clinical Genetics, 12, 249\u2013260.","journal-title":"The Application of Clinical Genetics"},{"issue":"10","key":"e_1_3_5_14_1","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1080\/15548627.2021.1938914","article-title":"Autophagy in ovary and polycystic ovary syndrome: role, dispute and future perspective","volume":"17","author":"Kumariya S.","year":"2021","unstructured":"Kumariya, S., et\u00a0al., 2021. Autophagy in ovary and polycystic ovary syndrome: role, dispute and future perspective. Autophagy, 17 (10), 2706\u20132733.","journal-title":"Autophagy"},{"issue":"1","key":"e_1_3_5_15_1","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1038\/s41598-019-38944-6","article-title":"Alterations of sphingolipid metabolism in different types of polycystic ovary syndrome","volume":"9","author":"Li J.","year":"2019","unstructured":"Li, J., et\u00a0al., 2019. Alterations of sphingolipid metabolism in different types of polycystic ovary syndrome. Scientific Reports, 9 (1), 3204.","journal-title":"Scientific Reports"},{"issue":"4","key":"e_1_3_5_16_1","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.tjog.2019.05.003","article-title":"Dyslipidemia involvement in the development of polycystic ovary syndrome","volume":"58","author":"Liu Q.","year":"2019","unstructured":"Liu, Q., et\u00a0al., 2019. Dyslipidemia involvement in the development of polycystic ovary syndrome. Taiwanese Journal of Obstetrics & Gynecology, 58 (4), 447\u2013453.","journal-title":"Taiwanese Journal of Obstetrics & Gynecology"},{"issue":"5","key":"e_1_3_5_17_1","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0015-0282(03)00173-0","article-title":"Use of recombinant human chorionic gonadotropin in ovulation induction","volume":"79","author":"Ludwig M.","year":"2003","unstructured":"Ludwig, M., Doody, K.J., and Doody, K.M., 2003. Use of recombinant human chorionic gonadotropin in ovulation induction. Fertility and Sterility, 79 (5), 1051\u20131059.","journal-title":"Fertility and Sterility"},{"key":"e_1_3_5_18_1","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.cca.2017.06.021","article-title":"Urinary metabolomic analysis of intrahepatic cholestasis of pregnancy based on high performance liquid chromatography\/mass spectrometry","volume":"471","author":"Ma L.","year":"2017","unstructured":"Ma, L., et\u00a0al., 2017. Urinary metabolomic analysis of intrahepatic cholestasis of pregnancy based on high performance liquid chromatography\/mass spectrometry. Clinica Chimica Acta, 471, 292\u2013297.","journal-title":"Clinica Chimica Acta"},{"key":"e_1_3_5_19_1","doi-asserted-by":"crossref","first-page":"865748","DOI":"10.3389\/fendo.2022.865748","article-title":"Arachidonic acid in follicular fluid of PCOS induces oxidative stress in a human ovarian granulosa tumor cell line (KGN) and upregulates GDF15 expression as a response","volume":"13","author":"Ma Y.","year":"2022","unstructured":"Ma, Y., et\u00a0al., 2022. Arachidonic acid in follicular fluid of PCOS induces oxidative stress in a human ovarian granulosa tumor cell line (KGN) and upregulates GDF15 expression as a response. Frontiers Endocrinology, 13, 865748.","journal-title":"Frontiers Endocrinology"},{"issue":"1","key":"e_1_3_5_20_1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12978-021-01073-3","article-title":"Impact of myo-inositol treatment in women with polycystic ovary syndrome in assisted reproductive technologies","volume":"18","author":"Merviel P.","year":"2021","unstructured":"Merviel, P., et\u00a0al., 2021. Impact of myo-inositol treatment in women with polycystic ovary syndrome in assisted reproductive technologies. Reproductive Health, 18 (1), 13.","journal-title":"Reproductive Health"},{"issue":"1","key":"e_1_3_5_21_1","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1186\/s12967-024-05167-x","article-title":"Integrated lipid metabolomics and proteomics analysis reveal the pathogenesis of polycystic ovary syndrome","volume":"22","author":"Qian Y.","year":"2024","unstructured":"Qian, Y., et\u00a0al., 2024. Integrated lipid metabolomics and proteomics analysis reveal the pathogenesis of polycystic ovary syndrome. Journal of Translational Medicine, 22 (1), 364.","journal-title":"Journal of Translational Medicine"},{"issue":"1","key":"e_1_3_5_22_1","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1021\/acs.analchem.6b02930","article-title":"Interlaboratory reproducibility of a targeted metabolomics platform for analysis of human serum and plasma","volume":"89","author":"Siskos A.P.","year":"2017","unstructured":"Siskos, A.P., et\u00a0al., 2017. Interlaboratory reproducibility of a targeted metabolomics platform for analysis of human serum and plasma. Analytical Chemistry, 89 (1), 656\u2013665.","journal-title":"Analytical Chemistry"},{"issue":"3","key":"e_1_3_5_23_1","doi-asserted-by":"crossref","first-page":"684","DOI":"10.3390\/genes5030684","article-title":"MicroRNAs related to polycystic ovary syndrome (PCOS)","volume":"5","author":"S\u00f8rensen A.E.","year":"2014","unstructured":"S\u00f8rensen, A.E., et\u00a0al., 2014. MicroRNAs related to polycystic ovary syndrome (PCOS). Genes, 5 (3), 684\u2013708.","journal-title":"Genes"},{"key":"e_1_3_5_24_1","first-page":"10164","article-title":"Serum lipidomics characterization of breast cancer progression in a transgenic mouse model of PyMT-induced breast cancer","volume":"8","author":"Xu J.","year":"2023","unstructured":"Xu, J., et\u00a0al., 2023. Serum lipidomics characterization of breast cancer progression in a transgenic mouse model of PyMT-induced breast cancer. Journal of Oncology Research and Therapy, 8, 10164.","journal-title":"Journal of Oncology Research and Therapy"},{"key":"e_1_3_5_25_1","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.2147\/DMSO.S421947","article-title":"Analysis of methylome, transcriptome, and lipid metabolites to understand the molecular abnormalities in polycystic ovary syndrome","volume":"16","author":"Zhang F.","year":"2023","unstructured":"Zhang, F., et\u00a0al., 2023. Analysis of methylome, transcriptome, and lipid metabolites to understand the molecular abnormalities in polycystic ovary syndrome. Diabetes, Metabolic Syndrome and Obesity, 16, 2745\u20132763.","journal-title":"Diabetes, Metabolic Syndrome and Obesity"},{"key":"e_1_3_5_26_1","doi-asserted-by":"crossref","first-page":"821","DOI":"10.3389\/fendo.2019.00821","article-title":"TMT based proteomic analysis of human follicular fluid from overweight\/obese and normal-weight patients with polycystic ovary syndrome","volume":"10","author":"Zhang X.","year":"2019","unstructured":"Zhang, X., et\u00a0al., 2019. TMT based proteomic analysis of human follicular fluid from overweight\/obese and normal-weight patients with polycystic ovary syndrome. Frontiers in Endocrinology, 10, 821.","journal-title":"Frontiers in Endocrinology"}],"container-title":["Journal of Obstetrics and Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/01443615.2024.2378489","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:59:43Z","timestamp":1761663583000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/01443615.2024.2378489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,17]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12,31]]}},"alternative-id":["10.1080\/01443615.2024.2378489"],"URL":"https:\/\/doi.org\/10.1080\/01443615.2024.2378489","relation":{},"ISSN":["0144-3615","1364-6893"],"issn-type":[{"value":"0144-3615","type":"print"},{"value":"1364-6893","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,17]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijog20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijog20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-09-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2378489"}}